Clinical Trials Browser

Phase 1 × Influenza Vaccines × 90 days × Clear all

NCT04697576 2026-03-10

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Phase 1 Recruiting

Melanoma